CAS 841-67-8: (-)-Thalidomide
Formula:C13H10N2O4
InChI:InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)/t9-/m0/s1
InChI key:InChIKey=UEJJHQNACJXSKW-VIFPVBQESA-N
SMILES:O=C1N(C(=O)C=2C1=CC=CC2)[C@@H]3C(=O)NC(=O)CC3
Synonyms:- (-)-Thalidomide
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (S)-
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (S)- (9CI)
- 1H-isoindole-1,3(2H)-dione, 2-[(3S)-2,6-dioxo-3-piperidinyl]-
- 2-[(3S)-2,6-Dioxo-3-piperidinyl]-1H-isoindole-1,3(2H)-dione
- 2-[(3S)-2,6-Dioxopiperidin-3-yl]-2,3-dihydro-1H-isoindole-1,3-dione
- 841-67-8
- NSC 91730
- Phthalimide, N-(2,6-dioxo-3-piperidyl)-, <span class="text-smallcaps">L</span>-(-)-
- S-(-)-Thalidomide
- S-(<span class="text-smallcaps">L</span>)-Thalidomide
- See more synonyms
Sort by
Found 7 products.
(S)-(-)-Thalidomide
CAS:Controlled ProductThalidomide is a drug that is used to treat human immunodeficiency, but has been found to have some side effects. It is an immunomodulatory drug that alters the immune system by suppressing the production of cytokines such as TNF-α and IL-1β. Thalidomide inhibits the production of prostaglandins, which are inflammatory mediators. It also has been shown to be effective in treating erythema nodosum leprosum and Behçet's disease. The molecular structure of thalidomide contains two chiral centers: carbonyl group and chlorine. The (S) form is more active than its enantiomer (R). Thalidomide can cause serious adverse reactions, including peripheral neuropathy, constipation, hiccoughs, tachycardia, insomnia, dizziness, nausea and vomiting.Formula:C13H10N2O4Purity:Min. 95%Molecular weight:258.23 g/mol(S)-Thalidomide
CAS:(S)-Thalidomide ((S)-(-)-Thalidomide) has anti-angiogenic activity and pro-apoptotic activity and can be used in the study of erythema nodosum in leprosy.Formula:C13H10N2O4Purity:99.84%Color and Shape:NeedlesMolecular weight:258.23(S)-(-)-Thalidomide
CAS:Controlled ProductApplications Optically active isomer of Thalidomide, which inhibits FGF-induced angiogenesis. Inhibits replication of human immunodeficiency virus type 1. Teratogenic sedative. References D’Amato, r.J., et al.: Proc. Natl. Acad. Sci. USA, 91, 4082 (1994), Makonkawkeyoon, S., et al.: Proc. Natl. Acad. Sci. USA, 90, 5974 (1993), Schumacher, H., et al.: J. Pharmacol. Exp. Therap., 160, 189 (1968)Formula:C13H10N2O4Color and Shape:White To Off-WhiteMolecular weight:258.23
